St. Jude's Ilumien Optis System Hits Japan
Japan is the first market to offer St. Jude's Ilumen Optis system, a next-generation technology designed to help physicians make personalized stenting decisions based on each patient’s unique anatomy and disease state. “ The new system is the latest in percutaneous coronary intervention (PCI) optimization technology, and helps physicians understand the needs of each patient, ultimately resulting in better medical decision making and overall cost-effective treatment,” says William Phillips, president of St. Jude Medical Japan
The device, which the company says is the only of its kind, uses fractional flow reserve (FFR) in conjunction with optical coherence tomography (OCT) imaging technology to give physicians a physiological and anatomical view of the coronary vessels. The FFR and OCT measurements allow physicians to more easily differentiate plaque build-up and determine if the narrowed arteries are causing ischemia, or a restriction in blood flow, ultimately assisting in stent placement.
“The Ilumien Optis system enables a higher image resolution, and thus makes it possible for us to analyze difficult anatomical structures, allowing me to focus on diagnostic and treatment strategies,” says Dr. Takashi Akasaka of Wakayama Medical University. “Also, this new analytical tool will be helpful for sizing and placing the stent. This technology has become increasingly important to help efficiently diagnose and treat patients.”
Th Ilumien Optis' OCT technology uses an imaging catheter to capture near-infrared light imaging and measure important vessel characteristics otherwise invisible or difficult to assess with older intracoronary imaging tools. This creates high-resolution setting and realtime, 3-D reconstruction that offers a 360-degree panoramic view of the vessel. This three-dimensional representation, which has previously only been available off-line and not in real time, enables better visualization in preparation for stenting and evaluation of the stent’s position once placed. St. Jude says the potential in this is to help physicians diagnose their patients more quickly.
to post comments